IPL for Dry Eye in Brooklyn

In 2021, the FDA granted De Novo authorization to Lumenis's IPL device, launched as OptiLight, for improving signs of dry eye disease caused by meibomian gland dysfunction. It was the first IPL device authorized for a dry eye indication. Dr. Rachel Mindin holds Lumenis OptiLight IPL certification, so patients at New York Laser Vision are treated by a provider trained on this platform.

IPL is not right for everyone. According to a 2019 review in Clinical Optometry, IPL cannot be used on skin darker than Fitzpatrick type IV, because more deeply pigmented skin faces a higher risk of damage. The same review found IPL may be less helpful for people whose dry eye comes purely from low tear production rather than oil gland problems, long-standing, advanced disease in which the oil glands have wasted away, and patients with other ongoing issues, such as incomplete blinking, previous LASIK, contact lens wear, or certain medications like some antidepressants and diuretics. Your provider will review your eyes, skin, and medical history before recommending treatment.

OptiLight is indicated for Fitzpatrick skin types I through IV, which cover light to medium-brown skin tones; shorter wavelengths interact more readily with skin pigment, so light filters are matched to skin type. A study in Photobiomodulation, Photomedicine, and Laser Surgery found IPL safe and effective for patients with skin types III and IV. If IPL is not a safe match, New York Laser Vision offers other in-office dry eye treatments.

Come to your appointment with a clean face. According to a 2019 review in Clinical Optometry, the treatment area must be free of makeup and shaved, then covered with ultrasound gel. Protective shields are placed over your eyes throughout the session, and treatment intensity is adjusted based on your skin type. Bring a full list of your medications, since the same review notes that certain drugs, including some antidepressants and diuretics, may reduce how well IPL works.

Most patients return to work or normal activities the same day. The treated skin may look slightly red or feel warm for a few hours. The treatment protocol described in EyeWiki includes applying sunscreen afterward and avoiding sun exposure for the first 48 hours. Continue daily broad-spectrum sunscreen throughout your treatment series.

Results vary with how severe the meibomian gland dysfunction is. Because dry eye is chronic, the benefits of an initial series do not last indefinitely. In one prospective, randomized, masked study, the effects had worn off by about nine months. That is why maintenance sessions are often recommended. Your provider will suggest a schedule based on how your glands respond.

Yes. Ocular rosacea affects up to three-quarters of people with rosacea. The same resource explains that IPL helps by clearing the tiny dilated blood vessels and reducing redness. As a side benefit, many patients see less redness on the cheeks and nose near the treatment area. Learn more about rosacea care at New York Laser Vision.

Yes, and it is designed to be. The FDA's authorization describes IPL as an add-on to therapies such as meibomian gland expression, artificial tears, and warm compresses. Your provider may also pair it with prescription anti-inflammatory drops, punctal plugs, amniotic membranes, or autologous serum tears. The team at the Brooklyn Accredited Dry Eye Center builds combination plans around each patient's tear film test results.

If you have meibomian gland dysfunction, treating it before surgery is often recommended. According to a European Society of Cataract and Refractive Surgeons (ESCRS) report, an unstable tear film can make pre-surgery measurements inaccurate or hard to repeat. The same report notes that most surgeons it surveyed agree that even mild dry eye can affect lens implant calculations. Improving tear quality first gives your surgeon more reliable data.

Insurance coverage for IPL is limited. An international health technology assessment found no coverage policies for IPL as a dry eye treatment. It also noted that at least one major U.S. insurer considers the treatment investigational and does not cover it. You can review payment options on the Financing & Insurance page.